Application of the PKCYP test to predict caffeine clearance mediated by CYP1A2 in a rat acute liver injury model.
暂无分享,去创建一个
[1] Magnus Ingelman-Sundberg,et al. Polymorphism of cytochrome P450 and xenobiotic toxicity. , 2002, Toxicology.
[2] R. Kim,et al. Pharmacogenomics of organic anion-transporting polypeptides (OATP). , 2002, Advanced drug delivery reviews.
[3] H. McLeod,et al. Genetic basis of drug metabolism. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[4] E. Nakashima,et al. Simultaneous assessment of the in vivo amount of CYP1A2 and CYP3A2 by the PKCYP-test using theophylline in rats. , 2002, Drug metabolism and pharmacokinetics.
[5] H. Iizasa,et al. Application of the PKCYP-test to predict the amount of in vivo CYP2C11 using tolbutamide as a probe. , 2001, Biological & pharmaceutical bulletin.
[6] H. Iizasa,et al. Application of the PKCYP-test in cases of altered CYP1A2 for multiple CYP systems in rat models of disease. , 2001, Biological & pharmaceutical bulletin.
[7] U. Brinkmann,et al. Polymorphisms in the ABC drug transporter gene MDR1 , 2001, The Pharmacogenomics Journal.
[8] J. Villeneuve,et al. Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. , 2000, Canadian journal of physiology and pharmacology.
[9] M. Fukuhara,et al. A Simplified Diagnostic Approach for Estimating in vivo Hepatic Drug Clearance. Its Preliminary Application for the Drug Caffeine, Using CYP1A Probe in a Rat Model.:Its Preliminary Application for the Drug Caffeine, Using CYP1A Probe in a Rat Model , 2000 .
[10] A. Nafziger,et al. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. , 2000, Pharmacogenetics.
[11] R. Obach,et al. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[12] T Ishizaki,et al. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. , 1997, Pharmacology & therapeutics.
[13] E. Tanaka,et al. Changes in the metabolism of three model substrates catalysed by different P450 isozymes when administered as a cocktail to the carbon tetrachloride-intoxicated rat. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.
[14] M. Fukuhara,et al. Characterization of benzo[a]pyrene metabolism and related cytochrome P-450 isozymes in Syrian hamster livers. , 1995, Journal of toxicology and environmental health.
[15] J B Houston,et al. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. , 1994, Biochemical pharmacology.
[16] B. Ring,et al. In vitro methods for assessing human hepatic drug metabolism: their use in drug development. , 1993, Drug metabolism reviews.
[17] Fukuhara Morio,et al. Aflatoxin B1-specific cytochrome P-450 isozyme (P-450-AFB) inducible by 3-methylcholanthrene in golden hamsters. , 1990 .
[18] M. Ishidate,et al. Characterization of three forms of cytochrome P-450 inducible by 3-methylcholanthrene in Golden hamster livers with special reference to aflatoxin B1 activation. , 1989, Journal of Biochemistry (Tokyo).
[19] A. Tsuji,et al. Effects of fasting on biperiden pharmacokinetics in the rat. , 1987, Journal of Pharmacy and Science.
[20] K. Yamaoka,et al. Moment analysis for disposition kinetics of several cephalosporin antibiotics in rats , 1983, The Journal of pharmacy and pharmacology.